MiR-375 and miR-30d in the effect of chromium-containing chinese medicine moderating glucose metabolism

Journal of Diabetes Research

Volumn 2014, Issue , 2014, Pages

  Zhang, Qian ^a   Xiao, Xinhua ^a   Li, Ming ^a   Li, Wenhui ^a   Yu, Miao ^a   Zhang, Huabing ^a   Ping, Fan ^a   Wang, Zhixin ^a   Zheng, Jia ^a   Xiang, Hongding ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CHINESE DRUG; CHROMIUM; INSULIN; MICRORNA; MICRORNA 10B; MICRORNA 134; MICRORNA 142; MICRORNA 188; MICRORNA 200A; MICRORNA 208; MICRORNA 296; MICRORNA 301B; MICRORNA 30D; MICRORNA 336; MICRORNA 375; MICRORNA 448; MICRORNA 500; MICRORNA 501; MICRORNA 540; MICRORNA 652; MICRORNA 874; MICRORNA 879; MICRORNA 880; TIANMAI XIAOKE; UNCLASSIFIED DRUG; CHROMIUM DERIVATIVE; HERBACEOUS AGENT; MIRN30 MICRORNA, RAT; MIRN375 MICRORNA, RAT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DIABETES MELLITUS; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; INSULIN RELEASE; INSULIN RESISTANCE; LOW DRUG DOSE; MALE; MICROARRAY ANALYSIS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; RAT; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; BLOOD; BODY WEIGHT; DOSE RESPONSE; DRUG EFFECT; HYPERGLYCEMIA; HYPERINSULINISM; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; RANDOMIZATION; SECRETION (PROCESS); SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; BODY WEIGHT; CHROMIUM; CHROMIUM COMPOUNDS; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; HYPERGLYCEMIA; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; MICRORNAS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 84900324766     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2014/862473     Document Type: Article

References (26)

1. Kowluru V., Kowluru R. A., Increased oxidative stress in diabetes regulates activation of a small molecular weight G-protein, H-Ras, in the retina. Molecular Vision 2007 13 602 610 2-s2.0-34247403051 (Pubitemid 46638505)
2. Cefalu W. T., Hu F. B., Role of chromium in human health and in diabetes. Diabetes Care 2004 27 11 2741 2751 2-s2.0-7444270286 10.2337/diacare.27.11.2741 (Pubitemid 39441482)
3. Abdollahi M., Farshchi A., Nikfar S., Effect of chromium on glucose and lipid profiles in patients with type 2 diabetes, a meta-analysis review of randomized trials. Journal of Pharmaceutical Sciences 2013 16 1 99 114
4. Schachter S., Nelson R. W., Kirk C. A., Oral chromium picolinate and control of glycemia in insulin-treated diabetic dogs. Journal of Veterinary Internal Medicine 2001 15 4 379 384 2-s2.0-0035409284 (Pubitemid 33722450)
5. Shao C., Lv X. F., Xiao X. H., Efficacy of Tianmaixiaoke tables in the treatment of newly diagnosed type 2 diabetes mellitus in China. National Medical Journal of China 2012 92 22 1522 1526
6. Bartel D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009 136 2 215 233 2-s2.0-58249088751 10.1016/j.cell.2009.01.002
7. Krützfeldt J., Rajewsky N., Braich R., Rajeev K. G., Tuschl T., Manoharan M., Stoffel M., Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005 438 7068 685 689 2-s2.0-28444469246 10.1038/nature04303 (Pubitemid 41740580)
8. Krützfeldt J., Stoffel M., MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metabolism 2006 4 1 9 12 2-s2.0-33745338485 10.1016/j.cmet.2006.05.009 (Pubitemid 43942256)
9. Esau C. C., Monia B. P., Therapeutic potential for microRNAs. Advanced Drug Delivery Reviews 2007 59 2-3 101 114 2-s2.0-34248634004 10.1016/j.addr.2007.03.007 (Pubitemid 46773050)
10. Chiba Y., Hijikata T., MicroRNAs and their therapeutic potential for human diseases: preface. Journal of Pharmacological Sciences 2010 114 3 262 263 2-s2.0-78649421048 10.1254/jphs.10R09FM
11. Qin S., Zhang C., MicroRNAs in vascular disease. Journal of Cardiovascular Pharmacology 2011 57 1 8 12 2-s2.0-78951485433 10.1097/FJC.0b013e318203759b
12. Farazi T. A., Spitzer J. I., Morozov P., Tuschl T., MiRNAs in human cancer. Journal of Pathology 2011 223 2 102 115 2-s2.0-78650034475 10.1002/path.2806
13. Reed M. J., Meszaros K., Entes L. J., Claypool M. D., Pinkett J. G., Gadbois T. M., Reaven G. M., A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism: Clinical and Experimental 2000 49 11 1390 1394 2-s2.0-0033761823 10.1053/meta.2000.17721
14. Huang J. H., Huang X. H., Chen Z. Y., Dose conversion among different animals and healthy volunteers in pharmacological study. Chinese Journal of Clinical Pharmacology and Therapeutics 2004 9 1069 1072
15. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262 (Pubitemid 34164012)
16. Rhodes M. C., Hébert C. D., Herbert R. A., Morinello E. J., Roycroft J. H., Travlos G. S., Abdo K. M., Absence of toxic effects in F344/N rats and B6C3F1 mice following subchronic administration of chromium picolinate monohydrate. Food and Chemical Toxicology 2005 43 1 21 29 2-s2.0-9644303166 10.1016/j.fct.2004.08.006 (Pubitemid 39575729)
17. Anderson R. A., Roussel A.-M., Zouari N., Mahjoub S., Matheau J.-M., Kerkeni A., Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. Journal of the American College of Nutrition 2001 20 3 212 218 2-s2.0-0034950133 (Pubitemid 32606167)
18. Anderson R. A., Cheng N., Bryden N. A., Polansky M. M., Cheng N., Chi J., Feng J., Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 1997 46 11 1786 1791 2-s2.0-0030695031 (Pubitemid 27456412)
19. Kleefstra N., Houweling S. T., Bakker S. J. L., Verhoeven S., Gans R. O. B., Meyboom-De Jong B., Bilo H. J. G., Chromium treatment has no effect in patients with type 2 diabetes in a western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care 2007 30 5 1092 1096 2-s2.0-34247618258 10.2337/dc06-2192 (Pubitemid 46684630)
20. Komorowski J., Juturu V., Gunton J. E., Cheung N. W., Hitchman R., Hams G., Sullivan C., Foster-Powell K., McElduff A., Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance: response to Gunton et al. Diabetes Care 2005 28 7 1841 1842 2-s2.0-21544448862
21. Albarracin C. A., Fuqua B. C., Evans J. L., Goldfine I. D., Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes/Metabolism Research and Reviews 2008 24 1 41 51 2-s2.0-38749135432 10.1002/dmrr.755 (Pubitemid 351175999)
22. Martin J., Wang Z. Q., Zhang X. H., Wachtel D., Volaufova J., Matthews D. E., Cefalu W. T., Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care 2006 29 8 1826 1832 2-s2.0-33746601010 10.2337/dc06-0254 (Pubitemid 44156637)
23. Poy M. N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X., MacDonald P. E., Pfeffer S., Tuschl T., Rajewsky N., Rorsman P., Stoffel M., A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004 432 7014 226 230 2-s2.0-9144270691 10.1038/nature03076 (Pubitemid 39545853)
24. Poy M. N., Hausser J., Trajkovski M., Braun M., Collins S., Rorsman P., Zavolan M., Stoffel M., miR-375 maintains normal pancreatic α-and β -cell mass. Proceedings of the National Academy of Sciences of the United States of America 2009 106 14 5813 5818 2-s2.0-65249093130 10.1073/pnas.0810550106
25. Ouaamari A. E., Baroukh N., Martens G. A., Lebrun P., Pipeleers D., Van Obberghen E., MiR-375 targets 3′l-Phosphoinositide-Dependent protein Kinase-1 and regulates Glucose-Induced biological responses in pancreatic β -cells. Diabetes 2008 57 10 2708 2717 2-s2.0-58149350343 10.2337/db07-1614
26. Tang X., Muniappan L., Tang G., Özcan S., Identification of glucose-regulated miRNAs from pancreatic β cells reveals a role for miR-30d in insulin transcription. RNA 2009 15 2 287 293 2-s2.0-58249107416 10.1261/rna.1211209